Chinese medicine for curing cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombus

A technology for the sequelae of cerebral hemorrhage and cerebral infarction, which can be used in blood diseases, drug combinations, pharmaceutical formulations, etc., can solve the problem of high drug dependence, and achieve the effect of stable blood pressure

Inactive Publication Date: 2008-08-27
刘玉安
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The present invention aims to solve the problem of high drug dependence of existing drugs for treating sequelae of cerebral hemorrhage, cerebral infar...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0018] Specific embodiment one: the traditional Chinese medicine for the treatment of cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombosis in this embodiment consists of 10 to 20 parts of antelope horn, 15 to 25 parts of whole worm, 10 to 20 parts of Uncaria, 15-25 parts of silkworm, 10-20 parts of white aconite, 15-25 parts of cassia twig, 10-20 parts of Fangfeng, 10-25 parts of frankincense, 10-20 parts of ephedra, 15-30 parts of Gastrodia elata, 3-7.5 parts of musk and 15-25 parts of angelica.

specific Embodiment approach 2

[0019] Specific embodiment two: The traditional Chinese medicine for the treatment of cerebral hemorrhage sequela, cerebral infarction and cerebral thrombosis in this embodiment consists of 13-18 parts of antelope horn, 18-22 parts of whole worm, 13-18 parts of Uncaria, 18-22 parts of silkworm, 12-17 parts of white aconite, 17-23 parts of cassia twig, 12-17 parts of Fangfeng, 15-20 parts of frankincense, 13-18 parts of ephedra, 20-25 parts of Gastrodia elata, 4-5.5 parts of musk and 18-22 parts of angelica.

specific Embodiment approach 3

[0020] Specific embodiment three: the Chinese medicine for the treatment of cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombosis of the present embodiment consists of 15 parts of antelope horns, 20 parts of whole insects, 15 parts of Uncaria, 20 parts of silkworms, 15 parts of Radix Aconiti, 20 parts of Guizhi, 15 parts of Fangfeng, 18 parts of Frankincense, 15 parts of Ephedra, 22 parts of Tianma, 4.5 parts of Musk and 20 parts of Angelica.

[0021] The traditional Chinese medicine for treating cerebral hemorrhage sequelae, cerebral infarction and cerebral thrombosis according to this embodiment is conventionally decocted, put into water 8 times the weight of the traditional Chinese medicine and decocted for 2-3 hours, and then filter out the medicinal liquid.

[0022] According to the dose of 300mL / time, the medicinal solution of the traditional Chinese medicine in this embodiment is taken every morning and evening for patients with sequelae of cerebral h...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a Chinese drug for curing sequelae of cerebral hemorrhage, cerebral infarction and cerebral thrombosis, which relates to a Chinese drug for the treatment of cardio-cerebrovascular diseases. The invention solves the problem of high drug dependence on the prior drug for curing the sequelae of the cerebral hemorrhage, the cerebral infarction and the cerebral thrombosis. The Chinese drug for curing the sequelae of the cerebral hemorrhage, the cerebral infarction and the cerebral thrombosis of the invention comprises the drugs calculated according to the amounts by weight that 10 to 20 parts of antelope horn, 15 to 25 parts of whole worm, 10 to 20 parts of uncaria atem with hooks, 15 to 25 parts of batryticated silkworm, 10 to 20 parts of giant typhomium tuber, 15 to 25 parts of cassia twig, 10 to 20 parts of ledebouriella root, 10 to 25 parts of frankincense, 10 to 20 parts of Chinese ephedra, 15 to 30 parts of gastrodia tuber, 3 to 7.5 parts of musk and 15 to 25 parts of Chinese angelica root. The total curative ratio of the Chinese drug for curing the sequelae of the cerebral hemorrhage, the cerebral infarction and the cerebral thrombosis of the invention is 40 percent, the total effective rate is 93.3 percent, and the patient has no drug dependence on the Chinese drug of invention.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases. Background technique [0002] Cerebral hemorrhage, cerebral infarction and cerebral thrombosis are frequent diseases of middle-aged and elderly people. Not only the mortality rate is high, but also these cardiovascular and cerebrovascular diseases will leave serious sequelae, ranging from trembling of hands and feet, facial twitching, to total paralysis. However, the current drugs for treating these heart and brain diseases have strong drug dependence, and the most obvious symptom is that the blood pressure on the day of stopping the drug is significantly higher than that during the period of taking the drug. Contents of the invention [0003] The invention aims to solve the problem of high drug dependence of existing drugs for treating sequelae of cerebral hemorrhage, cerebral infarction and cerebral thrombosis, and provides a traditiona...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8988A61P9/10A61P7/02A61K35/32A61K35/55A61K35/64
Inventor 刘玉安
Owner 刘玉安
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products